Mast cell depletion in the preclinical phase of collagen-induced arthritis reduces clinical outcome by lowering the inflammatory cytokine profile

Background Rheumatoid arthritis (RA) is a multifactorial autoimmune disease, which is characterized by inflammation of synovial joints leading to the destruction of cartilage and bone. Infiltrating mast cells can be found within the inflamed synovial tissue, however their role in disease pathogenesi...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Arthritis research & therapy Ročník 18; číslo 1; s. 138
Hlavní autoři:	van der Velden, Daniël, Lagraauw, H. Maxime, Wezel, Anouk, Launay, Pierre, Kuiper, Johan, Huizinga, Tom W. J., Toes, René E. M., Bot, Ilze, Stoop, Jeroen N.
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	London BioMed Central 13.06.2016 BioMed Central Ltd Springer Nature B.V
Témata:	Animals Arthritis Arthritis, Experimental - immunology Arthritis, Rheumatoid - immunology Care and treatment Clinical outcomes Collagen Cytokines Cytokines - biosynthesis Cytokines - immunology Development and progression Enzyme-Linked Immunosorbent Assay Flow Cytometry Genetic aspects Inflammation - immunology Mast cells Mast Cells - immunology Medicine Medicine & Public Health Mice Mice, Inbred DBA Mice, Knockout Orthopedics Patient outcomes Physiological aspects Research Article Rheumatoid arthritis Rheumatology France Netherlands RMB mice Mast cells T cells Collagen-induced arthritis
ISSN:	1478-6362, 1478-6354, 1478-6362
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Abstract	Background Rheumatoid arthritis (RA) is a multifactorial autoimmune disease, which is characterized by inflammation of synovial joints leading to the destruction of cartilage and bone. Infiltrating mast cells can be found within the inflamed synovial tissue, however their role in disease pathogenesis is unclear. Therefore we have studied the role of mast cells during different phases of experimental arthritis. Methods We induced collagen-induced arthritis (CIA), the most frequently used animal model of arthritis, in an inducible mast cell knock-out mouse and determined the effect of mast cell depletion on the development and severity of arthritis. Results Depletion of mast cells in established arthritis did not affect clinical outcome. However, depletion of mast cells during the preclinical phase resulted in a significant reduction in arthritis. This reduction coincided with a decrease in circulating CD4 + T cells and inflammatory monocytes but not in the collagen-specific antibody levels. Mast cell depletion resulted in reduced levels of IL-6 and IL-17 in serum. Furthermore, stimulation of splenocytes from mast cell-depleted mice with collagen type II resulted in reduced levels of IL-17 and enhanced production of IL-10. Conclusions Here we show that mast cells contribute to the preclinical phase of CIA. Depletion of mast cells before disease onset resulted in an altered collagen-specific T cell and cytokine response. These data may suggest that mast cells play a role in the regulation of the adaptive immune response during the development of arthritis.
AbstractList	Background Rheumatoid arthritis (RA) is a multifactorial autoimmune disease, which is characterized by inflammation of synovial joints leading to the destruction of cartilage and bone. Infiltrating mast cells can be found within the inflamed synovial tissue, however their role in disease pathogenesis is unclear. Therefore we have studied the role of mast cells during different phases of experimental arthritis. Methods We induced collagen-induced arthritis (CIA), the most frequently used animal model of arthritis, in an inducible mast cell knock-out mouse and determined the effect of mast cell depletion on the development and severity of arthritis. Results Depletion of mast cells in established arthritis did not affect clinical outcome. However, depletion of mast cells during the preclinical phase resulted in a significant reduction in arthritis. This reduction coincided with a decrease in circulating CD4+ T cells and inflammatory monocytes but not in the collagen-specific antibody levels. Mast cell depletion resulted in reduced levels of IL-6 and IL-17 in serum. Furthermore, stimulation of splenocytes from mast cell-depleted mice with collagen type II resulted in reduced levels of IL-17 and enhanced production of IL-10. Conclusions Here we show that mast cells contribute to the preclinical phase of CIA. Depletion of mast cells before disease onset resulted in an altered collagen-specific T cell and cytokine response. These data may suggest that mast cells play a role in the regulation of the adaptive immune response during the development of arthritis. Rheumatoid arthritis (RA) is a multifactorial autoimmune disease, which is characterized by inflammation of synovial joints leading to the destruction of cartilage and bone. Infiltrating mast cells can be found within the inflamed synovial tissue, however their role in disease pathogenesis is unclear. Therefore we have studied the role of mast cells during different phases of experimental arthritis.BACKGROUNDRheumatoid arthritis (RA) is a multifactorial autoimmune disease, which is characterized by inflammation of synovial joints leading to the destruction of cartilage and bone. Infiltrating mast cells can be found within the inflamed synovial tissue, however their role in disease pathogenesis is unclear. Therefore we have studied the role of mast cells during different phases of experimental arthritis.We induced collagen-induced arthritis (CIA), the most frequently used animal model of arthritis, in an inducible mast cell knock-out mouse and determined the effect of mast cell depletion on the development and severity of arthritis.METHODSWe induced collagen-induced arthritis (CIA), the most frequently used animal model of arthritis, in an inducible mast cell knock-out mouse and determined the effect of mast cell depletion on the development and severity of arthritis.Depletion of mast cells in established arthritis did not affect clinical outcome. However, depletion of mast cells during the preclinical phase resulted in a significant reduction in arthritis. This reduction coincided with a decrease in circulating CD4(+) T cells and inflammatory monocytes but not in the collagen-specific antibody levels. Mast cell depletion resulted in reduced levels of IL-6 and IL-17 in serum. Furthermore, stimulation of splenocytes from mast cell-depleted mice with collagen type II resulted in reduced levels of IL-17 and enhanced production of IL-10.RESULTSDepletion of mast cells in established arthritis did not affect clinical outcome. However, depletion of mast cells during the preclinical phase resulted in a significant reduction in arthritis. This reduction coincided with a decrease in circulating CD4(+) T cells and inflammatory monocytes but not in the collagen-specific antibody levels. Mast cell depletion resulted in reduced levels of IL-6 and IL-17 in serum. Furthermore, stimulation of splenocytes from mast cell-depleted mice with collagen type II resulted in reduced levels of IL-17 and enhanced production of IL-10.Here we show that mast cells contribute to the preclinical phase of CIA. Depletion of mast cells before disease onset resulted in an altered collagen-specific T cell and cytokine response. These data may suggest that mast cells play a role in the regulation of the adaptive immune response during the development of arthritis.CONCLUSIONSHere we show that mast cells contribute to the preclinical phase of CIA. Depletion of mast cells before disease onset resulted in an altered collagen-specific T cell and cytokine response. These data may suggest that mast cells play a role in the regulation of the adaptive immune response during the development of arthritis. Rheumatoid arthritis (RA) is a multifactorial autoimmune disease, which is characterized by inflammation of synovial joints leading to the destruction of cartilage and bone. Infiltrating mast cells can be found within the inflamed synovial tissue, however their role in disease pathogenesis is unclear. Therefore we have studied the role of mast cells during different phases of experimental arthritis. We induced collagen-induced arthritis (CIA), the most frequently used animal model of arthritis, in an inducible mast cell knock-out mouse and determined the effect of mast cell depletion on the development and severity of arthritis. Depletion of mast cells in established arthritis did not affect clinical outcome. However, depletion of mast cells during the preclinical phase resulted in a significant reduction in arthritis. This reduction coincided with a decrease in circulating CD4(+) T cells and inflammatory monocytes but not in the collagen-specific antibody levels. Mast cell depletion resulted in reduced levels of IL-6 and IL-17 in serum. Furthermore, stimulation of splenocytes from mast cell-depleted mice with collagen type II resulted in reduced levels of IL-17 and enhanced production of IL-10. Here we show that mast cells contribute to the preclinical phase of CIA. Depletion of mast cells before disease onset resulted in an altered collagen-specific T cell and cytokine response. These data may suggest that mast cells play a role in the regulation of the adaptive immune response during the development of arthritis. Background Rheumatoid arthritis (RA) is a multifactorial autoimmune disease, which is characterized by inflammation of synovial joints leading to the destruction of cartilage and bone. Infiltrating mast cells can be found within the inflamed synovial tissue, however their role in disease pathogenesis is unclear. Therefore we have studied the role of mast cells during different phases of experimental arthritis. Methods We induced collagen-induced arthritis (CIA), the most frequently used animal model of arthritis, in an inducible mast cell knock-out mouse and determined the effect of mast cell depletion on the development and severity of arthritis. Results Depletion of mast cells in established arthritis did not affect clinical outcome. However, depletion of mast cells during the preclinical phase resulted in a significant reduction in arthritis. This reduction coincided with a decrease in circulating CD4 + T cells and inflammatory monocytes but not in the collagen-specific antibody levels. Mast cell depletion resulted in reduced levels of IL-6 and IL-17 in serum. Furthermore, stimulation of splenocytes from mast cell-depleted mice with collagen type II resulted in reduced levels of IL-17 and enhanced production of IL-10. Conclusions Here we show that mast cells contribute to the preclinical phase of CIA. Depletion of mast cells before disease onset resulted in an altered collagen-specific T cell and cytokine response. These data may suggest that mast cells play a role in the regulation of the adaptive immune response during the development of arthritis.
ArticleNumber	138
Audience	Academic
Author	Huizinga, Tom W. J. Kuiper, Johan van der Velden, Daniël Launay, Pierre Lagraauw, H. Maxime Toes, René E. M. Stoop, Jeroen N. Wezel, Anouk Bot, Ilze
Author_xml	– sequence: 1 givenname: Daniël surname: van der Velden fullname: van der Velden, Daniël organization: Division of Biopharmaceutics, Leiden Academic Centre for Drug Research, Leiden University, Department of Rheumatology, Leiden University Medical Centre – sequence: 2 givenname: H. Maxime surname: Lagraauw fullname: Lagraauw, H. Maxime organization: Division of Biopharmaceutics, Leiden Academic Centre for Drug Research, Leiden University – sequence: 3 givenname: Anouk surname: Wezel fullname: Wezel, Anouk organization: Division of Biopharmaceutics, Leiden Academic Centre for Drug Research, Leiden University – sequence: 4 givenname: Pierre surname: Launay fullname: Launay, Pierre organization: Université Paris Diderot, Sorbonne Paris Cité, Laboratoire d’Excellence INFLAMEX, INSERM U1149, Centre de Recherche sur l’Inflammation, Université Paris Diderot – sequence: 5 givenname: Johan surname: Kuiper fullname: Kuiper, Johan organization: Division of Biopharmaceutics, Leiden Academic Centre for Drug Research, Leiden University – sequence: 6 givenname: Tom W. J. surname: Huizinga fullname: Huizinga, Tom W. J. organization: Department of Rheumatology, Leiden University Medical Centre – sequence: 7 givenname: René E. M. surname: Toes fullname: Toes, René E. M. email: r.e.m.toes@lumc.nl organization: Department of Rheumatology, Leiden University Medical Centre – sequence: 8 givenname: Ilze surname: Bot fullname: Bot, Ilze organization: Division of Biopharmaceutics, Leiden Academic Centre for Drug Research, Leiden University – sequence: 9 givenname: Jeroen N. surname: Stoop fullname: Stoop, Jeroen N. organization: Department of Rheumatology, Leiden University Medical Centre
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/27296719$$D View this record in MEDLINE/PubMed
BookMark	eNp9ks1u1DAUhSNURH_gAdggS2zYpNiOYzsbpKqigFTEBtaWx7mZcXHsYDtF8xi8cR2mLdMKkBf-O-e7ulfnuDrwwUNVvST4lBDJ3ybSYNHWmPCa4IbX8kl1RJiQNW84Pdg7H1bHKV1hTGlH2bPqkAracUG6o-rXZ50yMuAc6mFykG3wyHqUN4CmCMZZb412aNroBCgMyATn9Bp8bX0_G-iRjnkTbbYJRVheEro3hTmbMAJabZELPyFav_4Ntn5wehx1DnGLzDaH79Yv5cJgHTyvng7aJXhxu59U3y7efz3_WF9--fDp_OyyNhw3uTakASqlHDhAp2lrOJXClJtkqwZa3jJpysZM1_SGAel73rRdzwymGjMNzUn1bsed5tUIvQGfo3ZqinbUcauCturhj7cbtQ7XinVYYCoK4M0tIIYfM6SsRpuWSWoPYU6KiE7QhkjWFunrR9KrMEdf2lNEYiwpFhL_Ua21A1WGFEpds0DVGeNSCinpwjr9i6qsHkZrSkCWIT40vNpv9L7DuxAUgdgJTAwpRRiUsVkvSShk6xTBaomb2sVNlbipJW5KFid55LyD_89Dd540LYGAuDeLf5puANBH6WY
CitedBy_id	crossref_primary_10_1136_annrheumdis_2018_213418 crossref_primary_10_1038_s41467_023_44304_w crossref_primary_10_3389_fphar_2020_01051 crossref_primary_10_1155_2019_7592851 crossref_primary_10_1038_s42003_023_05208_z crossref_primary_10_3904_kjim_2019_271 crossref_primary_10_3390_ijms20082040 crossref_primary_10_3390_cells9122538 crossref_primary_10_1002_iid3_150 crossref_primary_10_1016_j_autrev_2017_04_001 crossref_primary_10_1111_papr_12551 crossref_primary_10_3390_life13081690 crossref_primary_10_3389_fimmu_2023_1275871 crossref_primary_10_1016_j_joca_2023_01_005 crossref_primary_10_1016_j_bbrc_2017_04_141 crossref_primary_10_1111_imr_12627 crossref_primary_10_3390_ijms22094972 crossref_primary_10_3389_fimmu_2018_01870 crossref_primary_10_4049_jimmunol_1601282 crossref_primary_10_1186_s13075_017_1326_9 crossref_primary_10_1186_s13075_021_02491_1 crossref_primary_10_1186_s41065_024_00310_6 crossref_primary_10_3389_fimmu_2020_00163 crossref_primary_10_3389_fimmu_2020_575792 crossref_primary_10_1016_j_intimp_2016_09_019
Cites_doi	10.1038/labinvest.2010.140 10.1172/JCI75212 10.3390/ijms131115107 10.1084/jem.20110845 10.1038/ni1005 10.1002/art.38996 10.1002/art.22602 10.1016/j.febslet.2011.04.034 10.1126/science.1073176 10.1007/BF02280992 10.1002/art.1780390318 10.1016/S1074-7613(02)00275-3 10.1038/nature01661 10.1038/ni1158 10.1136/ard.54.7.549 10.1084/jem.20011941 10.1073/pnas.85.17.6483 10.1164/rccm.200909-1338OC 10.1002/art.20001 10.1038/nm.2755 10.1038/337187a0 10.4049/jimmunol.167.6.3505 10.1002/art.24126 10.1186/ar578 10.1007/s00281-009-0189-9 10.1007/s10067-011-1737-y 10.1038/nrrheum.2011.204 10.1016/j.immuni.2006.01.001 10.1084/jem.20071391 10.1002/art.1780300202 10.1038/nprot.2006.393 10.3390/ijms131013438 10.1159/000237674 10.1038/nri3690 10.1016/j.immuni.2011.09.015 10.1038/nprot.2007.173 10.1002/art.22058 10.1038/nri2094 10.1146/annurev.immunol.21.120601.141025 10.1002/art.1780270802 10.1016/j.ejphar.2015.03.085 10.1002/(SICI)1097-4652(199710)173:1<10::AID-JCP2>3.0.CO;2-M 10.1016/j.immuni.2011.03.028 10.1002/art.21385 10.1084/jem.20070360 10.1084/jem.20061775 10.1186/s13075-015-0731-1 10.3892/etm.2015.2312 10.1046/j.1365-2567.2001.01267.x
ContentType	Journal Article
Copyright	The Author(s). 2016 COPYRIGHT 2016 BioMed Central Ltd. Copyright BioMed Central 2016
Copyright_xml	– notice: The Author(s). 2016 – notice: COPYRIGHT 2016 BioMed Central Ltd. – notice: Copyright BioMed Central 2016
DBID	C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM
DOI	10.1186/s13075-016-1036-8
DatabaseName	Springer Nature Open Access Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials AUTh Library subscriptions: ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) Medical Database ProQuest Central Premium ProQuest One Academic ProQuest Publicly Available Content ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles)
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	Publicly Available Content Database MEDLINE - Academic MEDLINE
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: PIMPY name: ProQuest Publicly Available Content url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1478-6362
ExternalDocumentID	PMC4907027 4105837771 A468878825 27296719 10_1186_s13075_016_1036_8
Genre	Research Support, Non-U.S. Gov't Journal Article
GeographicLocations	France Netherlands
GeographicLocations_xml	– name: Netherlands – name: France
GrantInformation_xml	– fundername: Hartstichting grantid: 2010B244; 2012T083 funderid: http://dx.doi.org/10.13039/501100002996 – fundername: Reumafonds grantid: 115142-2 funderid: http://dx.doi.org/10.13039/501100006315 – fundername: Universiteit Leiden (NL) grantid: Leiden Centre for Translational Drug Discovery & Development – fundername: ; grantid: Leiden Centre for Translational Drug Discovery & Development – fundername: ; grantid: 115142-2 – fundername: ; grantid: 2010B244; 2012T083
GroupedDBID	--- .GJ 0R~ 23N 2WC 4.4 5GY 5VS 6J9 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML ABUWG ACGFS ACJQM ADBBV ADUKV AEGXH AENEX AFKRA AFPKN AHBYD AHMBA AHSBF AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIAM AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK E3Z EBD EBLON EJD EMOBN F5P FYUFA GROUPED_DOAJ GX1 H13 HMCUK HYE HZ~ INH INR ITC KQ8 M1P O5R O5S O9- PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ ROL RPM RSV SMD SOJ SV3 TR2 U2A UKHRP WOQ AAYXX AFFHD CITATION ALIPV CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQUKI PRINS 7X8 5PM
ID	FETCH-LOGICAL-c603t-c13e2888f6ee9a25c6287cf6e84b3e56548ce564c93dc4e1dd6359d4c02a04ae3
IEDL.DBID	BENPR
ISICitedReferencesCount	30
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000377977300002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1478-6362 1478-6354
IngestDate	Tue Nov 04 02:01:03 EST 2025 Sun Nov 09 10:18:33 EST 2025 Mon Oct 06 18:29:07 EDT 2025 Tue Nov 11 10:58:49 EST 2025 Tue Nov 04 18:20:11 EST 2025 Mon Jul 21 06:00:57 EDT 2025 Sat Nov 29 06:09:46 EST 2025 Tue Nov 18 21:13:10 EST 2025 Sat Sep 06 07:28:21 EDT 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	1
Keywords	RMB mice Mast cells T cells Collagen-induced arthritis
Language	English
License	Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c603t-c13e2888f6ee9a25c6287cf6e84b3e56548ce564c93dc4e1dd6359d4c02a04ae3
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23
OpenAccessLink	https://www.proquest.com/docview/1800820780?pq-origsite=%requestingapplication%
PMID	27296719
PQID	1800820780
PQPubID	42876
ParticipantIDs	pubmedcentral_primary_oai_pubmedcentral_nih_gov_4907027 proquest_miscellaneous_1797231845 proquest_journals_1800820780 gale_infotracmisc_A468878825 gale_infotracacademiconefile_A468878825 pubmed_primary_27296719 crossref_citationtrail_10_1186_s13075_016_1036_8 crossref_primary_10_1186_s13075_016_1036_8 springer_journals_10_1186_s13075_016_1036_8
PublicationCentury	2000
PublicationDate	2016-06-13
PublicationDateYYYYMMDD	2016-06-13
PublicationDate_xml	– month: 06 year: 2016 text: 2016-06-13 day: 13
PublicationDecade	2010
PublicationPlace	London
PublicationPlace_xml	– name: London – name: England
PublicationTitle	Arthritis research & therapy
PublicationTitleAbbrev	Arthritis Res Ther
PublicationTitleAlternate	Arthritis Res Ther
PublicationYear	2016
Publisher	BioMed Central BioMed Central Ltd Springer Nature B.V
Publisher_xml	– name: BioMed Central – name: BioMed Central Ltd – name: Springer Nature B.V
References	M Costanza (1036_CR55) 2012; 13 JP Kinet (1036_CR26) 1988; 85 1036_CR54 D Maurer (1036_CR27) 1996; 157 ÅCM Johansson (1036_CR52) 2001; 167 M Veldhoen (1036_CR42) 2006; 24 TB Feyerabend (1036_CR15) 2011; 35 A Willemze (1036_CR53) 2012; 8 DG Malone (1036_CR7) 1987; 30 M Maccioni (1036_CR16) 2002; 195 TA Pimentel (1036_CR35) 2011; 91 H Ji (1036_CR17) 2002; 16 A Dahdah (1036_CR22) 2014; 124 A Porcherie (1036_CR25) 2011; 208 DD Brand (1036_CR28) 2007; 2 E Lubberts (1036_CR47) 2004; 50 A Alunno (1036_CR31) 2015; 2015 SJ Galli (1036_CR8) 2005; 23 S Alzabin (1036_CR19) 2011; 585 GS Firestein (1036_CR1) 2003; 423 A Iemura (1036_CR34) 1994; 144 M Fujimoto (1036_CR44) 2008; 58 DTSL Jansen (1036_CR20) 2015; 17 M Walmsley (1036_CR50) 1996; 39 JB McLachlan (1036_CR41) 2003; 4 Y Tanaka (1036_CR51) 1996; 45 K Shin (1036_CR11) 2009; 182 S Wernersson (1036_CR38) 2014; 14 SJ Galli (1036_CR32) 2012; 18 TWJ Huizinga (1036_CR4) 2005; 52 MH Grayson (1036_CR24) 2007; 204 A Amedei (1036_CR56) 2012; 13 A Dudeck (1036_CR36) 2011; 34 P Tang (1036_CR39) 2015; 9 M Kneilling (1036_CR14) 2007; 56 K Shin (1036_CR37) 2006; 54 DM Lee (1036_CR12) 2002; 297 AJ Crisp (1036_CR6) 1984; 27 K Sato (1036_CR46) 2006; 203 U Blank (1036_CR23) 1989; 337 LC Tetlow (1036_CR33) 1995; 54 JF Marcelletti (1036_CR40) 1991; 147 JA Luross (1036_CR18) 2001; 103 AJ Hueber (1036_CR49) 2010; 184 1036_CR21 SA Metawi (1036_CR48) 2011; 30 SJ Galli (1036_CR9) 2005; 6 JS Zhou (1036_CR13) 2007; 204 A Shetty (1036_CR45) 2014; 8 C Carlens (1036_CR3) 2010; 181 IB McInnes (1036_CR5) 2007; 7 K Saneyoshi (1036_CR43) 1997; 114 E Lubberts (1036_CR30) 2010; 32 LM Khachigian (1036_CR29) 2006; 1 AJ Silman (1036_CR2) 2002; 4 C Dobigny (1036_CR10) 1997; 173 25180604 - J Clin Invest. 2014 Oct;124(10):4577-89 25943290 - Eur J Pharmacol. 2016 May 5;778:116-24 21874405 - Clin Rheumatol. 2011 Sep;30(9):1201-7 3548731 - Arthritis Rheum. 1987 Feb;30(2):130-7 22561833 - Nat Med. 2012 May 04;18(5):693-704 11869678 - Immunity. 2002 Feb;16(2):157-68 24903914 - Nat Rev Immunol. 2014 Jul;14(7):478-94 8607899 - Arthritis Rheum. 1996 Mar;39(3):495-503 8752908 - J Immunol. 1996 Jul 15;157(2):607-16 19035481 - Arthritis Rheum. 2008 Dec;58(12):3710-9 6466393 - Arthritis Rheum. 1984 Aug;27(8):845-51 25918479 - Mediators Inflamm. 2015 ;2015 :751793 25510234 - Arthritis Rheumatol. 2015 Apr;67(4):903-13 11544344 - J Immunol. 2001 Sep 15;167(6):3505-12 19109198 - J Immunol. 2009 Jan 1;182(1):647-56 9326444 - J Cell Physiol. 1997 Oct;173(1):10-8 24729685 - Drug Des Devel Ther. 2014 Mar 28;8:349-64 16473830 - Immunity. 2006 Feb;24(2):179-89 26290328 - Arthritis Res Ther. 2015 Aug 20;17:220 17525752 - Nat Rev Immunol. 2007 Jun;7(6):429-42 14872510 - Arthritis Rheum. 2004 Feb;50(2):650-9 17546023 - Nat Protoc. 2007;2(5):1269-75 20203245 - Am J Respir Crit Care Med. 2010 Jun 1;181(11):1217-22 21967768 - J Exp Med. 2011 Oct 24;208(11):2225-36 17406499 - Nat Protoc. 2006;1(5):2512-6 7668897 - Ann Rheum Dis. 1995 Jul;54(7):549-55 20714326 - Lab Invest. 2011 Jan;91(1):33-42 7508684 - Am J Pathol. 1994 Feb;144(2):321-8 17530709 - Arthritis Rheum. 2007 Jun;56(6):1806-16 22293763 - Nat Rev Rheumatol. 2012 Jan 31;8(3):144-52 16947397 - Arthritis Rheum. 2006 Sep;54(9):2863-71 11529930 - Immunology. 2001 Aug;103(4):407-16 21703544 - Immunity. 2011 Jun 24;34(6):973-84 14595438 - Nat Immunol. 2003 Dec;4(12):1199-205 23203114 - Int J Mol Sci. 2012 Nov 16;13(11):15107-25 12748655 - Nature. 2003 May 15;423(6937):356-61 16255021 - Arthritis Rheum. 2005 Nov;52(11):3433-8 11956298 - J Exp Med. 2002 Apr 15;195(8):1071-7 17998392 - J Exp Med. 2007 Nov 26;204(12):2797-802 17954569 - J Exp Med. 2007 Oct 29;204(11):2759-69 8814459 - Inflamm Res. 1996 Jun;45(6):283-8 12215644 - Science. 2002 Sep 6;297(5587):1689-92 15662442 - Nat Immunol. 2005 Feb;6(2):135-42 1753095 - J Immunol. 1991 Dec 15;147(12):4185-91 2521376 - Nature. 1989 Jan 12;337(6203):187-9 22101159 - Immunity. 2011 Nov 23;35(5):832-44 12110146 - Arthritis Res. 2002;4 Suppl 3:S265-72 23202961 - Int J Mol Sci. 2012 Oct 19;13(10):13438-60 2970642 - Proc Natl Acad Sci U S A. 1988 Sep;85(17):6483-7 9363904 - Int Arch Allergy Immunol. 1997 Nov;114(3):237-45 17088434 - J Exp Med. 2006 Nov 27;203(12):2673-82 15771585 - Annu Rev Immunol. 2005;23:749-86 26136859 - Exp Ther Med. 2015 May;9(5):1567-1571 20127485 - Semin Immunopathol. 2010 Mar;32(1):43-53 20200272 - J Immunol. 2010 Apr 1;184(7):3336-40 21515267 - FEBS Lett. 2011 Dec 1;585(23):3649-59
References_xml	– volume: 91 start-page: 33 year: 2011 ident: 1036_CR35 publication-title: Lab Invest. doi: 10.1038/labinvest.2010.140 – volume: 124 start-page: 4577 year: 2014 ident: 1036_CR22 publication-title: J Clin Invest. doi: 10.1172/JCI75212 – volume: 13 start-page: 15107 year: 2012 ident: 1036_CR55 publication-title: Int J Mol Sci. doi: 10.3390/ijms131115107 – volume: 208 start-page: 2225 year: 2011 ident: 1036_CR25 publication-title: J Exp Med. doi: 10.1084/jem.20110845 – volume: 8 start-page: 349 year: 2014 ident: 1036_CR45 publication-title: Drug Des Devel Ther. – volume: 182 start-page: 647 year: 2009 ident: 1036_CR11 publication-title: J Immunol Baltim Md 1950 – volume: 4 start-page: 1199 year: 2003 ident: 1036_CR41 publication-title: Nat Immunol. doi: 10.1038/ni1005 – volume: 157 start-page: 607 year: 1996 ident: 1036_CR27 publication-title: J Immunol Baltim Md 1950 – ident: 1036_CR21 doi: 10.1002/art.38996 – volume: 56 start-page: 1806 year: 2007 ident: 1036_CR14 publication-title: Arthritis Rheum. doi: 10.1002/art.22602 – volume: 184 start-page: 3336 year: 2010 ident: 1036_CR49 publication-title: J Immunol Baltim Md 1950 – volume: 585 start-page: 3649 year: 2011 ident: 1036_CR19 publication-title: FEBS Lett. doi: 10.1016/j.febslet.2011.04.034 – volume: 297 start-page: 1689 year: 2002 ident: 1036_CR12 publication-title: Science. doi: 10.1126/science.1073176 – volume: 45 start-page: 283 year: 1996 ident: 1036_CR51 publication-title: Inflamm Res. doi: 10.1007/BF02280992 – volume: 2015 start-page: 751793 year: 2015 ident: 1036_CR31 publication-title: Mediators Inflamm. – volume: 39 start-page: 495 year: 1996 ident: 1036_CR50 publication-title: Arthritis Rheum. doi: 10.1002/art.1780390318 – volume: 16 start-page: 157 year: 2002 ident: 1036_CR17 publication-title: Immunity. doi: 10.1016/S1074-7613(02)00275-3 – volume: 423 start-page: 356 year: 2003 ident: 1036_CR1 publication-title: Nature. doi: 10.1038/nature01661 – volume: 6 start-page: 135 year: 2005 ident: 1036_CR9 publication-title: Nat Immunol. doi: 10.1038/ni1158 – volume: 54 start-page: 549 year: 1995 ident: 1036_CR33 publication-title: Ann Rheum Dis. doi: 10.1136/ard.54.7.549 – volume: 195 start-page: 1071 year: 2002 ident: 1036_CR16 publication-title: J Exp Med. doi: 10.1084/jem.20011941 – volume: 85 start-page: 6483 year: 1988 ident: 1036_CR26 publication-title: Proc Natl Acad Sci U S A. doi: 10.1073/pnas.85.17.6483 – volume: 181 start-page: 1217 year: 2010 ident: 1036_CR3 publication-title: Am J Respir Crit Care Med. doi: 10.1164/rccm.200909-1338OC – volume: 50 start-page: 650 year: 2004 ident: 1036_CR47 publication-title: Arthritis Rheum. doi: 10.1002/art.20001 – volume: 18 start-page: 693 year: 2012 ident: 1036_CR32 publication-title: Nat Med. doi: 10.1038/nm.2755 – volume: 337 start-page: 187 year: 1989 ident: 1036_CR23 publication-title: Nature. doi: 10.1038/337187a0 – volume: 167 start-page: 3505 year: 2001 ident: 1036_CR52 publication-title: J Immunol doi: 10.4049/jimmunol.167.6.3505 – volume: 58 start-page: 3710 year: 2008 ident: 1036_CR44 publication-title: Arthritis Rheum. doi: 10.1002/art.24126 – volume: 4 start-page: S265 issue: Suppl 3 year: 2002 ident: 1036_CR2 publication-title: Arthritis Res. doi: 10.1186/ar578 – volume: 32 start-page: 43 year: 2010 ident: 1036_CR30 publication-title: Semin Immunopathol. doi: 10.1007/s00281-009-0189-9 – volume: 147 start-page: 4185 year: 1991 ident: 1036_CR40 publication-title: J Immunol Baltim Md 1950 – volume: 30 start-page: 1201 year: 2011 ident: 1036_CR48 publication-title: Clin Rheumatol. doi: 10.1007/s10067-011-1737-y – volume: 8 start-page: 144 year: 2012 ident: 1036_CR53 publication-title: Nat Rev Rheumatol. doi: 10.1038/nrrheum.2011.204 – volume: 24 start-page: 179 year: 2006 ident: 1036_CR42 publication-title: Immunity. doi: 10.1016/j.immuni.2006.01.001 – volume: 204 start-page: 2797 year: 2007 ident: 1036_CR13 publication-title: J Exp Med. doi: 10.1084/jem.20071391 – volume: 30 start-page: 130 year: 1987 ident: 1036_CR7 publication-title: Arthritis Rheum. doi: 10.1002/art.1780300202 – volume: 1 start-page: 2512 year: 2006 ident: 1036_CR29 publication-title: Nat Protoc. doi: 10.1038/nprot.2006.393 – volume: 13 start-page: 13438 year: 2012 ident: 1036_CR56 publication-title: Int J Mol Sci. doi: 10.3390/ijms131013438 – volume: 114 start-page: 237 year: 1997 ident: 1036_CR43 publication-title: Int Arch Allergy Immunol. doi: 10.1159/000237674 – volume: 14 start-page: 478 year: 2014 ident: 1036_CR38 publication-title: Nat Rev Immunol. doi: 10.1038/nri3690 – volume: 35 start-page: 832 year: 2011 ident: 1036_CR15 publication-title: Immunity. doi: 10.1016/j.immuni.2011.09.015 – volume: 2 start-page: 1269 year: 2007 ident: 1036_CR28 publication-title: Nat Protoc. doi: 10.1038/nprot.2007.173 – volume: 54 start-page: 2863 year: 2006 ident: 1036_CR37 publication-title: Arthritis Rheum. doi: 10.1002/art.22058 – volume: 7 start-page: 429 year: 2007 ident: 1036_CR5 publication-title: Nat Rev Immunol. doi: 10.1038/nri2094 – volume: 23 start-page: 749 year: 2005 ident: 1036_CR8 publication-title: Annu Rev Immunol. doi: 10.1146/annurev.immunol.21.120601.141025 – volume: 27 start-page: 845 year: 1984 ident: 1036_CR6 publication-title: Arthritis Rheum. doi: 10.1002/art.1780270802 – ident: 1036_CR54 doi: 10.1016/j.ejphar.2015.03.085 – volume: 173 start-page: 10 year: 1997 ident: 1036_CR10 publication-title: J Cell Physiol. doi: 10.1002/(SICI)1097-4652(199710)173:1<10::AID-JCP2>3.0.CO;2-M – volume: 34 start-page: 973 year: 2011 ident: 1036_CR36 publication-title: Immunity. doi: 10.1016/j.immuni.2011.03.028 – volume: 144 start-page: 321 year: 1994 ident: 1036_CR34 publication-title: Am J Pathol. – volume: 52 start-page: 3433 year: 2005 ident: 1036_CR4 publication-title: Arthritis Rheum. doi: 10.1002/art.21385 – volume: 204 start-page: 2759 year: 2007 ident: 1036_CR24 publication-title: J Exp Med. doi: 10.1084/jem.20070360 – volume: 203 start-page: 2673 year: 2006 ident: 1036_CR46 publication-title: J Exp Med. doi: 10.1084/jem.20061775 – volume: 17 start-page: 220 year: 2015 ident: 1036_CR20 publication-title: Arthritis Res Ther. doi: 10.1186/s13075-015-0731-1 – volume: 9 start-page: 1567 year: 2015 ident: 1036_CR39 publication-title: Exp Ther Med. doi: 10.3892/etm.2015.2312 – volume: 103 start-page: 407 year: 2001 ident: 1036_CR18 publication-title: Immunology. doi: 10.1046/j.1365-2567.2001.01267.x – reference: 11869678 - Immunity. 2002 Feb;16(2):157-68 – reference: 8752908 - J Immunol. 1996 Jul 15;157(2):607-16 – reference: 21703544 - Immunity. 2011 Jun 24;34(6):973-84 – reference: 11529930 - Immunology. 2001 Aug;103(4):407-16 – reference: 21874405 - Clin Rheumatol. 2011 Sep;30(9):1201-7 – reference: 11544344 - J Immunol. 2001 Sep 15;167(6):3505-12 – reference: 21967768 - J Exp Med. 2011 Oct 24;208(11):2225-36 – reference: 17998392 - J Exp Med. 2007 Nov 26;204(12):2797-802 – reference: 16947397 - Arthritis Rheum. 2006 Sep;54(9):2863-71 – reference: 22561833 - Nat Med. 2012 May 04;18(5):693-704 – reference: 2970642 - Proc Natl Acad Sci U S A. 1988 Sep;85(17):6483-7 – reference: 6466393 - Arthritis Rheum. 1984 Aug;27(8):845-51 – reference: 20203245 - Am J Respir Crit Care Med. 2010 Jun 1;181(11):1217-22 – reference: 17546023 - Nat Protoc. 2007;2(5):1269-75 – reference: 26136859 - Exp Ther Med. 2015 May;9(5):1567-1571 – reference: 24903914 - Nat Rev Immunol. 2014 Jul;14(7):478-94 – reference: 23202961 - Int J Mol Sci. 2012 Oct 19;13(10):13438-60 – reference: 2521376 - Nature. 1989 Jan 12;337(6203):187-9 – reference: 24729685 - Drug Des Devel Ther. 2014 Mar 28;8:349-64 – reference: 16255021 - Arthritis Rheum. 2005 Nov;52(11):3433-8 – reference: 9363904 - Int Arch Allergy Immunol. 1997 Nov;114(3):237-45 – reference: 25510234 - Arthritis Rheumatol. 2015 Apr;67(4):903-13 – reference: 14872510 - Arthritis Rheum. 2004 Feb;50(2):650-9 – reference: 19035481 - Arthritis Rheum. 2008 Dec;58(12):3710-9 – reference: 25180604 - J Clin Invest. 2014 Oct;124(10):4577-89 – reference: 14595438 - Nat Immunol. 2003 Dec;4(12):1199-205 – reference: 8607899 - Arthritis Rheum. 1996 Mar;39(3):495-503 – reference: 20127485 - Semin Immunopathol. 2010 Mar;32(1):43-53 – reference: 21515267 - FEBS Lett. 2011 Dec 1;585(23):3649-59 – reference: 15662442 - Nat Immunol. 2005 Feb;6(2):135-42 – reference: 25943290 - Eur J Pharmacol. 2016 May 5;778:116-24 – reference: 23203114 - Int J Mol Sci. 2012 Nov 16;13(11):15107-25 – reference: 17954569 - J Exp Med. 2007 Oct 29;204(11):2759-69 – reference: 7508684 - Am J Pathol. 1994 Feb;144(2):321-8 – reference: 20200272 - J Immunol. 2010 Apr 1;184(7):3336-40 – reference: 12215644 - Science. 2002 Sep 6;297(5587):1689-92 – reference: 17406499 - Nat Protoc. 2006;1(5):2512-6 – reference: 8814459 - Inflamm Res. 1996 Jun;45(6):283-8 – reference: 12110146 - Arthritis Res. 2002;4 Suppl 3:S265-72 – reference: 9326444 - J Cell Physiol. 1997 Oct;173(1):10-8 – reference: 17088434 - J Exp Med. 2006 Nov 27;203(12):2673-82 – reference: 1753095 - J Immunol. 1991 Dec 15;147(12):4185-91 – reference: 20714326 - Lab Invest. 2011 Jan;91(1):33-42 – reference: 19109198 - J Immunol. 2009 Jan 1;182(1):647-56 – reference: 26290328 - Arthritis Res Ther. 2015 Aug 20;17:220 – reference: 22101159 - Immunity. 2011 Nov 23;35(5):832-44 – reference: 15771585 - Annu Rev Immunol. 2005;23:749-86 – reference: 7668897 - Ann Rheum Dis. 1995 Jul;54(7):549-55 – reference: 17525752 - Nat Rev Immunol. 2007 Jun;7(6):429-42 – reference: 3548731 - Arthritis Rheum. 1987 Feb;30(2):130-7 – reference: 11956298 - J Exp Med. 2002 Apr 15;195(8):1071-7 – reference: 12748655 - Nature. 2003 May 15;423(6937):356-61 – reference: 22293763 - Nat Rev Rheumatol. 2012 Jan 31;8(3):144-52 – reference: 17530709 - Arthritis Rheum. 2007 Jun;56(6):1806-16 – reference: 16473830 - Immunity. 2006 Feb;24(2):179-89 – reference: 25918479 - Mediators Inflamm. 2015 ;2015 :751793
SSID	ssj0022924
Score	2.3272572
Snippet	Background Rheumatoid arthritis (RA) is a multifactorial autoimmune disease, which is characterized by inflammation of synovial joints leading to the... Rheumatoid arthritis (RA) is a multifactorial autoimmune disease, which is characterized by inflammation of synovial joints leading to the destruction of... Background Rheumatoid arthritis (RA) is a multifactorial autoimmune disease, which is characterized by inflammation of synovial joints leading to the...
SourceID	pubmedcentral proquest gale pubmed crossref springer
SourceType	Open Access Repository Aggregation Database Index Database Enrichment Source Publisher
StartPage	138
SubjectTerms	Animals Arthritis Arthritis, Experimental - immunology Arthritis, Rheumatoid - immunology Care and treatment Clinical outcomes Collagen Cytokines Cytokines - biosynthesis Cytokines - immunology Development and progression Enzyme-Linked Immunosorbent Assay Flow Cytometry Genetic aspects Inflammation - immunology Mast cells Mast Cells - immunology Medicine Medicine & Public Health Mice Mice, Inbred DBA Mice, Knockout Orthopedics Patient outcomes Physiological aspects Research Article Rheumatoid arthritis Rheumatology
SummonAdditionalLinks	– databaseName: Springer LINK Contemporary dbid: RSV link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bi9UwEA66ivji_VJdJYIgKGXbNE3bx0VcfNlFvLFvJU1SzuLaHk57hP0Z_mO_yUnLnoMK-lRKJmFIv0zydSYzjL20bVK1rdIxBEQsGxBWLZIibnLpcGDOra1aX2yiODkpT0-rD-Ee9zBFu08uSW-p_bIu1cEAa1tQoJmC6aAsulfZNex2Ja3Gj5--zixLgFEE9-Vvu21tQLtm-NI-tBsjueMo9fvP0e3_0vwOuxWOm_xwg4-77Irr7rEbx8Ghfp_9PNbDyOnvPbduSYm4-46fdRzHQr6EMQz3Jvlygd2O9y33uAHoYnB5oMJyQG_hEyPxFWWBdQOfO_XrEQo63lzwcyrGBp39wAA1cPjd-_e5uRj7b9CFh-rhD9iXo3ef376PQ5WG2KgkG2OTZk6AR7fKuUqL3CiQMIO3UjaZy6kuvcFDmiqzRrrUWpxxKitNInQitcsesr2u79xjxq1JUyUajGgLafFxdYNuudZONBZUIGLJ9OlqE1KYUyWN89pTmVLVm6muKWyNprouI_Z67rLc5O_4m_ArwkNNaxvjGh2uKEA7moD6UCrYZCiSR2x_SxJr0mw3T4iqg00Y6rT0562iTCL2Ym6mnhTn1rl-DZmCqsCBdWOIRxsAzmoL8CBVpFXEii1ozgKUKXy7pTtb-IzhsoJlF0XE3kwAvaTWn2bjyT9JP2U3BSGcyjpl-2xvXK3dM3bd_AAAV8_9Ev0FVzs7bQ priority: 102 providerName: Springer Nature
Title	Mast cell depletion in the preclinical phase of collagen-induced arthritis reduces clinical outcome by lowering the inflammatory cytokine profile
URI	https://link.springer.com/article/10.1186/s13075-016-1036-8 https://www.ncbi.nlm.nih.gov/pubmed/27296719 https://www.proquest.com/docview/1800820780 https://www.proquest.com/docview/1797231845 https://pubmed.ncbi.nlm.nih.gov/PMC4907027
Volume	18
WOSCitedRecordID	wos000377977300002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVADU databaseName: Open Access: BioMedCentral Open Access Titles customDbUrl: eissn: 1478-6362 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0022924 issn: 1478-6362 databaseCode: RBZ dateStart: 20030101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1478-6362 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0022924 issn: 1478-6362 databaseCode: DOA dateStart: 19990101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1478-6362 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0022924 issn: 1478-6362 databaseCode: 7X7 dateStart: 20150101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1478-6362 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0022924 issn: 1478-6362 databaseCode: BENPR dateStart: 20150101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Publicly Available Content customDbUrl: eissn: 1478-6362 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0022924 issn: 1478-6362 databaseCode: PIMPY dateStart: 20150101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVAVX databaseName: Springer Journals customDbUrl: eissn: 1478-6362 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0022924 issn: 1478-6362 databaseCode: RSV dateStart: 19990601 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwED-xDiFe-B4ERmUkJCRQtMRx4uQJDbQJHlpV40PlKUpsR50YSWhSpP0Z_MfcuW5YK7EXXlpF_tA5_vnOZ1_uB_BSV0FWVUnhYwXuixId1oIH0i9jYXDDHGudVZZsQk6n6XyezdyBW-fCKjc60Spq3Sg6Iz8KU2utZBq8bX_6xBpFt6uOQmMP9ilTmRjB_ruT6exscLl4tqa1FegroWkV7l4zTJOjDrW3pMC1BFURZeXdsky7-vmKgdoNnty5QbWG6fTu_w7pHtxxW1J2vMbQfbhh6gdwa-Iu3R_C70nR9YxO-Jk2LSXrbmp2XjPcOrIWFab7tpK1C7SIrKmYxRYC00d_H5GjGcJzYZMnsSVlijUdGxo1qx6FNay8ZBdE2IZDtB0j8BGrP2wMAFOXffMdZWGOYfwRfDk9-fz-g--YHHyVBFHvqzAyHH3tKjEmK3isEnTUFD6looxMTNz1Cv-EyiKthAm1xsnKtFABLwJRmOgARnVTmyfAtArDhJfYo5ZC43anKLFZXBSGlxrdBQ-CzSzmyqU5J7aNi9y6O2mSryc-p9A2mvg89eD10KRd5_i4rvIrgkZO6x_7VYX7jAGloxeQH4sE9TYKEntwuFUT163aLt6gInd6o8v_QsKDF0MxtaRYuNo0K6wjiSkOPXPs4vEai4PYHH2lRIaZB3ILpUMFyia-XVKfL2xWcZGh9ufSgzcbPF8R619v4-n1g3gGtzktMOJ6ig5h1C9X5jncVL8Qccsx7Mm5tL_p2C3csT0TwafZx8nsGz6dffr6B43xTqE
linkProvider	ProQuest
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEB6VFAEX3g9DgUUCIYGs2uv164BQBVSN2kQ5FKmcXHt3rUQU28QOKD-DP8JvZMYv6kj01gMny9qHNpOZ-Xa8s_MBvFSpFaapF5vYgZsiwYA15pZvJq7QuGF2lQrTmmzCn06Dk5NwtgW_u7swlFbZ-cTaUatc0jfyXTuo0coPrPfFd5NYo-h0taPQaNTiUK9_YshWvht_xP_3Fef7n44_HJgtq4ApPcupTGk7mmPcl3pahzF3pYdBg8S3QCSOdolHXeJDyNBRUmhbKcTkUAlp8dgSsXZw3iuwLVDZgxFsz8aT2Zc-xONhQ6MrMDbDYaI9R7UDb7dEtPApUc5D10dVgAdIuIkH5wBxM1lz48S2BsL9W_-bCG_DzXbLzfYaG7kDWzq7C9cmbVLBPfg1icuK0QkGU7qgYuR5xhYZw60xKxAQ2rujrJgj4rM8ZbXtoOGZi0yhZSiG5jevi0OxJVXC1SXrB-WrCoWjWbJmZ0RIhyKtJ0bDRlv8Vuc4MLmu8q-4FtYyqN-Hz5cikAcwyvJMPwKmpG17PMEZlS8UbufiBIe5cax5ojAcMsDqtCaSbRl3YhM5i-pwLvCiRtEiSt0jRYsCA970Q4qmhslFnV-TKkbk33BeGbfXNHB1JIBoT3iIS7gQ14CdQU_0S3LY3Glh1PrFMvqrgga86JtpJOX6ZTpfYR-fmPDsQOAUDxvd75fNMRb0fDs0wB9YRd-BqqUPW7LFvK6aLkJEN-4b8Lazn3PL-pc0Hl_8I57D9YPjyVF0NJ4ePoEbnIybeK2cHRhVy5V-ClflD9S-5bPWUTA4vWzD-gOsn6an
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1ti9QwEA56yuEX3_Wqp0YQBKVcm6Zp-_FQF0VvOfCF-xbSJGUP79qy7Qr3M_zHzqRpuS4qiJ9KySTMZp9M5mkmM4S8MFVUVJVQIQiwkJdAWBWLsrBMuQWHOTWmqFyxiWy5zE9OimNf57Qbo93HI8nhTgNmaar7g9ZUwxLPxUEHljfDoDMBZgQz6l4l1zjWDEK6_vnbxLgYsAt_lPnbbrPNaNskX9qTtuMltw5N3V60uPXfv-I2uendUHo44OYOuWLru2T3yB-03yM_j1TXU_yqT41tMUF3U9PTmoK7SFswkv4-JW1XsAvSpqIOTwDGEDg-oMVQgOTKJUyia8wOazs6dWo2PShraXlBz7BIG-jvBgawAz7P3bk_1Rd98x10ob6q-H3ydfHuy5v3oa_eEGoRJX2o48Qy4NeVsLZQLNUCyJmGt5yXiU2xXr2GB9dFYjS3sTHg-xSG64ipiCubPCA7dVPbPUKNjmPBShjRZNyAi6NK6JYqZVlpgCIEJBr_Rql9anOssHEmHcXJhRymWmI4G061zAPyaurSDnk9_ib8ErEhcc3DuFr5qwugHU6APOQCbDUokgZkfyYJa1XPm0d0SW8rOhnnzg_L8iggz6dm7Inxb7VtNiCTYXU4YOMwxMMBjJPaDPiRyOIiINkMppMAZhCft9SnK5dJnBdg8VkWkNcjWC-p9afZePRP0s_I7vHbhfz0YfnxMbnBEOxY-SnZJzv9emOfkOv6B2Bx_dSt3F_Dqkc1
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mast+cell+depletion+in+the+preclinical+phase+of+collagen-induced+arthritis+reduces+clinical+outcome+by+lowering+the+inflammatory+cytokine+profile&rft.jtitle=Arthritis+research+%26+therapy&rft.au=van+der+Velden%2C+DaniA%27l&rft.au=Lagraauw%2C+H.+Maxime&rft.au=Wezel%2C+Anouk&rft.au=Launay%2C+Pierre&rft.date=2016-06-13&rft.pub=BioMed+Central+Ltd&rft.issn=1478-6354&rft.volume=18&rft.issue=1&rft_id=info:doi/10.1186%2Fs13075-016-1036-8&rft.externalDocID=A468878825
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1478-6362&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1478-6362&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1478-6362&client=summon